CD40LG and Guillain-Barre syndrome: At the time of assessment in that study, unlike the current study, all living GBS case-patients were at least five months out from neurologic symptom onset and the laboratory criteria were based on a recent Flavivirus infection (a positive or equivocal IgM test result for ZIKV or dengue).